These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 16848762)

  • 21. [Meta-analysis of beta-adrenoceptor blockers for the treatment of vasovagal syncope].
    Liao Y; Li XY; Zhang YW; Du JB
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Dec; 40(6):603-9. PubMed ID: 19088832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is there an effective pharmacological treatment in the prevention of vasovagal syncope?
    Sutton R
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():25-28. PubMed ID: 8734160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can prodromal symptoms predict recurrence of vasovagal syncope?
    Fazelifar AF; Basiri HA; Tolooie A; Haghjoo M; Barakpour H; Emkanjoo Z; Abkenar HB; Zeighami M; Asgari F; Sadr-Ameli MA
    Cardiol J; 2008; 15(5):446-50. PubMed ID: 18810720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of frequency of recurrent syncope after beta-blocker therapy versus conservative management for patients with vasovagal syncope.
    Alegria JR; Gersh BJ; Scott CG; Hodge DO; Hammill SC; Shen WK
    Am J Cardiol; 2003 Jul; 92(1):82-4. PubMed ID: 12842256
    [No Abstract]   [Full Text] [Related]  

  • 25. Strategy for the management of vasovagal syncope.
    Bloomfield DM
    Drugs Aging; 2002; 19(3):179-202. PubMed ID: 12027777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vasovagal syncope].
    Nellessen E; Melon P; Kulbertus H
    Rev Med Liege; 1997 May; 52(5):324-8. PubMed ID: 9273633
    [No Abstract]   [Full Text] [Related]  

  • 27. Cerebral syncope in a patient with spinal cord injury.
    Bisharat N; Paz E; Klimov A; Friedberg N; Elias M
    Pacing Clin Electrophysiol; 2002 Mar; 25(3):372-3. PubMed ID: 11990670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of head-up tilt test with intravenous beta-blocker administration in assessing the efficacy of therapy in patients with vasovagal syncope.
    Gielerak G; Makowski K; Cholewa M
    Ann Noninvasive Electrocardiol; 2005 Jan; 10(1):65-72. PubMed ID: 15649240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized clinical trials of neurally mediated syncope.
    Brignole M
    J Cardiovasc Electrophysiol; 2003 Sep; 14(9 Suppl):S64-9. PubMed ID: 12950522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible involvement of cerebral hypoperfusion as trigger of neurally-mediated vasovagal syncope.
    Abe H; Kohshi K; Kuroiwa A
    Pacing Clin Electrophysiol; 1998 Mar; 21(3):613-6. PubMed ID: 9558695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of psychological factors in response to treatment in neurocardiogenic (vasovagal) syncope.
    Gracie J; Newton JL; Norton M; Baker C; Freeston M
    Europace; 2006 Aug; 8(8):636-43. PubMed ID: 16864617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of Syncope Trial (POST): a randomized clinical trial of beta blockers in the prevention of vasovagal syncope; rationale and study design.
    Sheldon R; Rose S; Connolly S
    Europace; 2003 Jan; 5(1):71-5. PubMed ID: 12504644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 'Front-loaded' head-up tilt table testing: validation of a rapid first line nitrate-provoked tilt protocol for the diagnosis of vasovagal syncope.
    Parry SW; Gray JC; Newton JL; Reeve P; O'Shea D; Kenny RA
    Age Ageing; 2008 Jul; 37(4):411-5. PubMed ID: 18586835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasodepressor syncope. Diagnosis and management.
    Barbey JT
    Cardiol Clin; 1997 May; 15(2):251-6. PubMed ID: 9164713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Home orthostatic training in vasovagal syncope modifies autonomic tone: results of a randomized, placebo-controlled pilot study.
    Ector H
    Europace; 2010 Jun; 12(6):910. PubMed ID: 20179177
    [No Abstract]   [Full Text] [Related]  

  • 36. Correlation of postural blood pressure test and head-up tilt table test in patients with vasovagal syncope.
    Aydin MA; Mortensen K; Meinertz T; Schuchert A; Willems S; Ventura R
    Cardiology; 2007; 107(4):380-5. PubMed ID: 17284899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The expectation effect and cardiac pacing for refractory vasovagal syncope.
    Sud S; Massel D; Klein GJ; Leong-Sit P; Yee R; Skanes AC; Gula LJ; Krahn AD
    Am J Med; 2007 Jan; 120(1):54-62. PubMed ID: 17208080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of pindolol in neurocardiogenic syncope.
    Iskos D; Dutton J; Scheinman MM; Lurie KG
    Am J Cardiol; 1998 Nov; 82(9):1121-4, A9. PubMed ID: 9817494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapy of vasovagal syncope (nonpharmacologic therapy and pharmacotherapy)].
    Mitro P
    Vnitr Lek; 2000 Dec; 46(12):861-8. PubMed ID: 11214367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized and controlled pilot trial of beta-blockers for the treatment of recurrent syncope in patients with a positive or negative response to head-up tilt test.
    Ventura R; Maas R; Zeidler D; Schoder V; Nienaber CA; Schuchert A; Meinertz T
    Pacing Clin Electrophysiol; 2002 May; 25(5):816-21. PubMed ID: 12049374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.